Cleared Traditional

K970831 - REMEL SPARFLOXACIN 5G SUSCEPTIBILTY DISK

K970831 is an FDA 510(k) clearance for REMEL SPARFLOXACIN 5G SUSCEPTIBILTY DISK, manufactured by Remel, Inc.. The device is a Class 2 Microbiology device with product code JTN cleared through the Traditional 510(k) pathway after a 26-day FDA review.

K970831 · Remel, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1997
Decision
26d
Days
Class 2
Risk

K970831 is an FDA 510(k) clearance for the REMEL SPARFLOXACIN 5G SUSCEPTIBILTY DISK. Classified as Susceptibility Test Discs, Antimicrobial (product code JTN), Class II - Special Controls.

Submitted by Remel, Inc. (Lenexa, US). The FDA issued a Cleared decision on April 2, 1997 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1620 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Remel, Inc. devices

FDA 510(k) Submission Details - K970831

510(k) Number K970831 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 07, 1997
Decision Date April 02, 1997
Days to Decision 26 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 102d · This submission: 26d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JTN Device Classification - Class 2, Special Controls

Product Code JTN Susceptibility Test Discs, Antimicrobial
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JTN Susceptibility Test Discs, Antimicrobial

All 314
Devices cleared under the same product code (JTN) and FDA review panel - the closest regulatory comparables to K970831.
AZITHROMYCIN ANTIMICROBIAL SUSCEPTIBILITY TEST DISC
K971635 · Oxoid , Ltd. · Jul 1997
DISPENS-O-DISC (TM) LEVOFLOXACIN
K971120 · Difco Laboratories, Inc. · Apr 1997
DISPENS-O-DISC SPARFLOXACIN
K971211 · Difco Laboratories, Inc. · Apr 1997
SPARFLOZACIN, 5 MCG, SENSI-DISC
K970385 · Becton Dickinson Microbiology Systems · Mar 1997
LEVOFLOXACIN, 5MCG, SENSI-DISC
K970212 · Becton Dickinson Microbiology Systems · Mar 1997
IMIPENEM ANTIMICROBIAL SUSCEPTIBILITY TEST DISC
K964487 · Unipath , Ltd. · Feb 1997